Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.
Press releases published on April 23, 2025
SELLAS to Present at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire
·
April 23, 2025
NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, …
PDS Biotech Announces Multiple Abstracts Selected for Presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire
·
April 23, 2025
PRINCETON, N.J., April 23, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced …
Embossed Film Market Size to be Worth US$ 28.81 Billion by 2031, Driven by Soaring Demand from the Packaging Industry, Report by The Insight Partners
GlobeNewswire
·
April 23, 2025
US …
WISeKey Expands Implementation of Digital Identity Solutions from Seychelles to Africa: Empowering Nations with Secure National ID Systems
GlobeNewswire
·
April 23, 2025
WISeKey Expands Implementation of Digital Identity Solutions from Seychelles to Africa: Empowering Nations with Secure National ID Systems Geneva, Switzerland – April 23, 2025 — WISeKey International Holding Ltd (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a …
Tealium customers achieve 25% increase in return-on-ad spend via CAPI integration capabilities
GlobeNewswire
·
April 23, 2025
San Diego, April 23, 2025 (GLOBE NEWSWIRE) -- Tealium is helping brands achieve an average 25% increase in return-on-ad-spend (ROAS) when utilizing its Conversions API (CAPI) integration capabilities. Being the first in the customer data platform (CDP) …
Cullinan Therapeutics to Present Results from REZILIENT1, a Phase 1/2 Trial of Zipalertinib in Patients with Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations Who Have Received Prior Therapy, at ASCO 2025
GlobeNewswire
·
April 23, 2025
CAMBRIDGE, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today announced that results from the REZILIENT1 study of zipalertinib …
Mersana Therapeutics Announces Upcoming Emi-Le Oral and Poster Presentations at ASCO 2025 Annual Meeting
GlobeNewswire
·
April 23, 2025
CAMBRIDGE, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of …
Allogene Therapeutics to Present Updated ALLO-316 Clinical Results in Kidney Cancer in Oral Presentation and ALPHA3 Trial-in-Progress Poster for Cema-Cel at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire
·
April 23, 2025
SOUTH SAN FRANCISCO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, today …
Update: Dental Implants and Prosthetics market to grow at a CAGR of 5.4% during the forecast period (2025 – 2030): Wissen Research
GlobeNewswire
·
April 23, 2025
Sheridan, April 23, 2025 (GLOBE NEWSWIRE) -- According to the latest market report published by Wissen Research, the global dental implants and prosthetics market is valued at 12.1 billion in 2024. Furthermore, the market is expected to grow at a CAGR of 5 …
Firefly Aerospace Awarded AFRL Contract to Develop Ceramic Matrix Composite Rocket Engine Nozzle Extension
GlobeNewswire
·
April 23, 2025
Built with lightweight composite material, nozzle extensions will lower costs, improve performance, and accelerate rocket engine production CEDAR PARK, Texas, April 23, 2025 (GLOBE NEWSWIRE) -- Firefly Aerospace, the leader in end-to-end responsive space …
Affimed Announces Acceptance of Three Abstracts for Presentation at the American Society for Clinical Oncology Annual Meeting
GlobeNewswire
·
April 23, 2025
MANNHEIM, Germany, April 23, 2025 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) (“Affimed”, or the “Company”), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced an abstract on …
BioAtla Announces Upcoming Poster Presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire
·
April 23, 2025
SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today …
Adagene Announces Upcoming Poster Presentation on Masked Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) at American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire
·
April 23, 2025
SAN DIEGO and SUZHOU, China, April 23, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced a poster presentation at ASCO 2025 in Chicago, …
Immix Biopharma’s NXC-201 NEXICART-2 Clinical Trial Data Selected for Oral Presentation at ASCO 2025
GlobeNewswire
·
April 23, 2025
— Oral presentation Tuesday, June 3, 2025 in Chicago — LOS ANGELES, April 23, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), a clinical-stage biopharmaceutical company developing cell therapies for AL …
Bicara Therapeutics to Present Updated Data from Ongoing Phase 1/1b Trial of Ficerafusp alfa in 1L R/M HNSCC at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire
·
April 23, 2025
BOSTON, April 23, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced that updated data from …
Immatics Announces Upcoming Oral and Poster Presentation on IMA203 TCR T-cell Therapy at 2025 ASCO Annual Meeting
GlobeNewswire
·
April 23, 2025
Houston, Texas and Tuebingen, Germany, April 23, 2025 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies, today …
iManage Announces Revealing New Research Report Around Law Firms and LegalTech
GlobeNewswire
·
April 23, 2025
CHICAGO, April 23, 2025 (GLOBE NEWSWIRE) -- iManage, the company dedicated to Making Knowledge Work™, today announced the availability of a new research report - Ground your legal AI strategy firmly in the basics - that distills survey responses from more …
RTD Alcoholic Beverages Market Size to Record a CAGR of 7.1% During 2025-2031, Driven by Increasing Demand for Innovative and Premium Beverages, Report by The Insight Partners
GlobeNewswire
·
April 23, 2025
US …
Holding(s) in Company
GlobeNewswire
·
April 23, 2025
The Board of Serabi announces that the Company has received the following TR-1 notification which is set out below. Serabi Gold plc Michael Hodgson Tel: +44 (0)20 7246 6830 Chief Executive Mobile: +44 (0)7799 473621 Andrew Khov Vice …
Caro Holdings Launches AI Chat Agent Platform to Revolutionize Customer Service and Boost Business Efficiency
GlobeNewswire
·
April 23, 2025
SHEFFIELD, United Kingdom, April 23, 2025 (GLOBE NEWSWIRE) -- Caro Holdings announces the release of its new AI Chat Agent platform - an intelligent, always-on assistant team built to help businesses save time, cut costs, and deliver top-tier customer …